Clinical Trials Related to Intellia Therapeutics

Related studies linked through entity extraction aliases.

A Phase 3 Study of NTLA-2001 in ATTRv-PN

Status: RECRUITING
Phase: PHASE3

HAELO: A Phase 3 Study to Evaluate NTLA-2002 in Participants With Hereditary Angioedema (HAE)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE3

NTLA-3001 in Adults with Alpha-1 Antitrypsin Deficiency-Associated Lung Disease

Status: WITHDRAWN
Phase: PHASE1/PHASE2

A Study to Investigate the Safety and Effectiveness of a Coagulation Factor IX Gene Insertion Therapy (REGV131-LNP1265) in Pediatric, Adolescent and Adult Participants With Hemophilia B

Status: RECRUITING
Phase: PHASE1/PHASE2

Long-Term Follow-Up (LTFU) of Subjects Treated With NTLA 2002

Status: ENROLLING_BY_INVITATION
Phase: N/A

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

Status: RECRUITING
Phase: PHASE3

Long-Term Follow-Up (LTFU) of Subjects Dosed With NTLA-2001

Status: RECRUITING
Phase: N/A

NTLA-2002 in Adults With Hereditary Angioedema (HAE)

Status: ACTIVE_NOT_RECRUITING
Phase: PHASE1/PHASE2

Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia

Status: TERMINATED
Phase: PHASE1/PHASE2

Study to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of NTLA-2001 in Patients With Hereditary Transthyretin Amyloidosis With Polyneuropathy (ATTRv-PN) and Patients With Transthyretin Amyloidosis-Related Cardiomyopathy (ATTR-CM)

Status: COMPLETED
Phase: PHASE1